Watch the full video on Youtube!

On November 18th, Clarivate™ released its annual “Highly Cited Researchers” report, recognising the pioneers in the fields of science and technology who produced multiple highly-cited papers ranking in the top 1% by citations in Web of Science™. Three Luxembourg researchers, including Dr Bohn, are featured in the 2020 edition of this prestigious international ranking.

In October 2020, the second phase of the Biomarkers in Food Allergy Diagnosis (APSIS) clinical trial was officially initiated under the coordination of the LIH Department of Infection and Immunity (DII) and in collaboration with the Centre Hospitalier du Luxembourg (CHL), the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg and the Integrated Biobank of Luxembourg (IBBL). This translational study aims to explore the correlation between the clinical and immunological characteristics of allergic patients with the functional features of the gut microbiome, ultimately supporting the development of novel translational strategies for the prevention of food allergies. Dr Annette Kuehn, Principal Investigator of the study and Group Leader of the Molecular and Translational Allergology unit of the LIH Department of Infection and Immunity (DII), explains the key aspects of the project.

The Department of Population Health (DoPH) is aninterdisciplinary department that focuses on research in epidemiology, publichealth and clinical research across a wide range of fields. The DoPH overseesepidemiological studies, clinical trials, and experimental investigations ofchronic diseases. To reinforce its team within the DoPH, the Public HealthExpertise (PHE) Unit has an opening for an experienced epidemiologist to work on the OSCOUR-Lux project for the establishment of a syndromic surveillance systems for public health surveillance.

Under the responsibility of the CEO, the Chief Medical Information Officer (CMIO) provides the necessary leadership to ensure that LIH’s information technology applications, platforms and infrastructure are fully integrated to support its research and translational strategy.The CMIO will also lead the creation of an integrated big data platform that will allow Luxembourg’s research community and national/international stakeholders to access integrated clinical and research data, as well as health insurance and social security data. The successful candidate will make sure that information technology and the use of artificial intelligence are as solid as to support and enable transformational system change, in close cooperation with other main key stakeholders, such as health-related government bodies and hospitals.

he Laboratory Technician will work onsetting up Disease Modeling Screening Platform (DMSP) in Luxembourg.  Disease ModelingScreening platform is a core faciclity for translational research inLuxembourg. He/she will mainly work on early drugdiscovery project at Disease modeling Screening Platform (DMSP).

Launch of a study on the exposure to pollutants of children living in Luxembourg.

WEBINAR: Lecture series Cancer Research: "Targeting DNA repair: from basic biology to clinical trials"- Prof Thomas Helleday

To be part of the Neuro-Immunology Group (Head: Dr. A. Michelucci) within the Department of Oncolgy at the LIH, we are currently looking for a PhD student.